Literature DB >> 31339054

Circular RNA expression profiles in cisplatin-induced acute kidney injury in mice.

Can-Ming Li1, Ming Li1, Zeng-Chun Ye1, Jia-Yan Huang1, Yin Li1, Zi-Ying Yao1, Hui Peng1, Tan-Qi Lou1.   

Abstract

Aim: This study was carried out to identify the expression profile and role of circRNAs in cisplatin-induced acute kidney injury (AKI). Materials & methods: In this study, an AKI model was established in cisplatin-treated mice, and the expression of circRNAs was profiled by next-generation sequencing. The differential expression levels of selected circRNAs were determined by quantitative real-time polymerase chain reaction. Bioinformatics analysis was conducted to predict the functions.
Results: In total, 368 circRNAs were detected to be differentially expressed in response to cisplatin treatment. Bioinformatics analysis indicated that the parental genes of the differentially expressed circRNAs were predominantly implicated in the cell and cell part, cellular process and cancer pathways.
Conclusion: CircRNAs might be differentially expressed in AKI, which are potentially involved in pathophysiology of cisplatin-induced nephrotoxicity.

Entities:  

Keywords:  RNA-Seq; acute kidney injury; circular RNA; cisplatin; microRNA

Mesh:

Substances:

Year:  2019        PMID: 31339054     DOI: 10.2217/epi-2018-0167

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  9 in total

1.  Silencing circ_0074371 inhibits the progression of sepsis-induced acute kidney injury by regulating miR-330-5p/ELK1 axis.

Authors:  Qiu-Yuan Wang; Rong-Rong Zhang; Long Cui; Ya-Ping Sun
Journal:  Mamm Genome       Date:  2022-08-22       Impact factor: 3.224

Review 2.  Cisplatin nephrotoxicity: new insights and therapeutic implications.

Authors:  Chengyuan Tang; Man J Livingston; Robert Safirstein; Zheng Dong
Journal:  Nat Rev Nephrol       Date:  2022-10-13       Impact factor: 42.439

Review 3.  The Intersection of Acute Kidney Injury and Non-Coding RNAs: Inflammation.

Authors:  Bojun Li; Fangyou Lin; Yuqi Xia; Zehua Ye; Xinzhou Yan; Baofeng Song; Tianhui Yuan; Lei Li; Xiangjun Zhou; Weimin Yu; Fan Cheng
Journal:  Front Physiol       Date:  2022-06-09       Impact factor: 4.755

Review 4.  Circular RNAs in kidney disease and cancer.

Authors:  Anton Jan van Zonneveld; Malte Kölling; Roel Bijkerk; Johan M Lorenzen
Journal:  Nat Rev Nephrol       Date:  2021-08-11       Impact factor: 28.314

5.  Alteration of N6-Methyladenosine RNA Profiles in Cisplatin-Induced Acute Kidney Injury in Mice.

Authors:  Can-Ming Li; Ming Li; Wen-Bo Zhao; Zeng-Chun Ye; Hui Peng
Journal:  Front Mol Biosci       Date:  2021-07-09

Review 6.  Circular RNAs in Acute Kidney Injury: Roles in Pathophysiology and Implications for Clinical Management.

Authors:  Benjamin Y F So; Desmond Y H Yap; Tak Mao Chan
Journal:  Int J Mol Sci       Date:  2022-07-31       Impact factor: 6.208

7.  Regulation Networks of Non-Coding RNA-Associated ceRNAs in Cisplatin-Induced Acute Kidney Injury.

Authors:  Yun Ding; Shengfeng Wan; Wenna Liu; Yanfang Lu; Qin Xu; Yujin Gan; Lei Yan; Yue Gu; Ziyang Liu; Yifeng Hu; Huixia Cao; Fengmin Shao
Journal:  Cells       Date:  2022-09-23       Impact factor: 7.666

8.  circMTND5 Participates in Renal Mitochondrial Injury and Fibrosis by Sponging MIR6812 in Lupus Nephritis.

Authors:  Junjun Luan; Congcong Jiao; Cong Ma; Yixiao Zhang; Xiangnan Hao; Guangyu Zhou; Jingqi Fu; Xingyu Qiu; Hongyu Li; Wei Yang; Gabor G Illei; Jeffrey B Kopp; Jingbo Pi; Hua Zhou
Journal:  Oxid Med Cell Longev       Date:  2022-10-11       Impact factor: 7.310

Review 9.  Circular RNA in renal diseases.

Authors:  Juan Jin; Haolu Sun; Chao Shi; Hui Yang; Yiwan Wu; Wanhai Li; Yu-Hang Dong; Liang Cai; Xiao-Ming Meng
Journal:  J Cell Mol Med       Date:  2020-04-25       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.